Fibrosis 5/19/2021tiroidea y mediastínica con aortitis en una mujer de 49 años

  1. Abassi Pérez, A. 1
  2. Pretel Ruiz, P. 1
  3. Bohórquez Heras, C. 1
  4. Montaño Tapia, L. 1
  1. 1 Servicio de Reumatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España
Revue:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Année de publication: 2021

Titre de la publication: Enfermedades del sistema inmune (V)

Serie: 13

Número: 32

Pages: 1865-1866

Type: Article

DOI: 10.1016/J.MED.2021.04.018 DIALNET GOOGLE SCHOLAR

D'autres publications dans: Medicine: Programa de Formación Médica Continuada Acreditado

Objectifs de Développement Durable

Références bibliographiques

  • Wallace ZS, Naden RP, Chari S, Choi HK, Della Torre E, Dicaire JF. Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4 related disease. Ann Rheum Dis. 2020;79(1):77-87.
  • Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA. Rituximab for IgG4 related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171-7.
  • Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN. Second International Symposium on IgG4-Related Disease. International Consensus Guidance Statement on the management and treatment of IgG4 related disease. Arthritis Rheumatol. 2015;67(7):1688-99.
  • Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607-15.
  • Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C. An International Multispecialty Validation Study of the IgG4 Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018;70(11):1671-8
La source de données: Dialnet